• X4 Pharmaceuticals Completes Merger with Arsanis pharmaceutical-technology
    March 14, 2019
    X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the completion of its merger with Arsanis, Inc., effective as of March 13, 2019.
PharmaSources Customer Service